PF-Atlas › Drugs › hydroxychloroquine

hydroxychloroquine

Idiopathic Pulmonary Fibrosis

Clinical trials
2
Developer
Vanderbilt University

Overview

hydroxychloroquine is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

hydroxychloroquine clinical trials

NCT00311883 (Phase 1)NCT05841758 (Phase 4)

Explore related

All trialsResearch
Medical disclaimer. This page summarizes research about hydroxychloroquine for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.